Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 10 - 04 symbols : JNJ save search
Xencor and Janssen Unite Again in Second Bispecific Antibodies Agreement
Published: 2021-10-04 (Crawled : 22:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.98%
H: 0.63%
C: -0.48%
antibody
Bentley University Announces Vaccination Requirement for Home Indoor Athletic Events
Published: 2021-10-04 (Crawled : 20:00) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.4%
H: 0.78%
C: -0.18%
vaccine
Novavax Announces Leadership Appointment and Updates
Published: 2021-10-04 (Crawled : 20:00) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.4%
H: 0.78%
C: -0.18%
NVAX | $4.15 -0.96% -0.96% 2.4M
|
Health Technology
|
| O: 1.81%
H: 2.04%
C: -6.34%
COVID-19 Update: J&J to Request Booster Authorization, Merck Antiviral Review a Priority
Published: 2021-10-04 (Crawled : 17:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.98%
H: 0.63%
C: -0.48%
covid antiviral authorized covid-19
Global Molecular Diagnostics Markets Analysis & Forecasts, 2016-2020 & 2021-2026 with COVID-19 Impact Insights
Published: 2021-10-04 (Crawled : 16:00) - prnewswire.com
TMO | News | $577.39 0.49% 0.0% 2M
|
Health Technology
|
| O: -0.2%
H: 0.52%
C: -0.45%
QGEN | $41.52 -0.88% 0.0% 820K
|
Health Technology
|
| O: -0.02%
H: 0.26%
C: -0.69%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.98%
H: 0.63%
C: -0.48%
DHR | $250.41 -1.07% -0.72% 3.3M
|
Health Technology
|
| O: -0.19%
H: 0.62%
C: -1.05%
BDX | $233.83 -0.23% 3.49% 780K
|
Health Technology
|
| O: -0.44%
H: 1.51%
C: -1.26%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: -0.51%
H: 0.82%
C: -0.93%
QGEN | $41.52 -0.88% 0.0% 820K
|
Health Technology
|
| O: -0.02%
H: 0.26%
C: -0.69%
covid molecular diagnostics molecular diagnostics diagnostic
Clinical Catch-Up: September 27-October 1
Published: 2021-10-04 (Crawled : 14:15) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.98%
H: 0.63%
C: -0.48%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.54%
H: 0.77%
C: 0.17%
New Analysis Presented by Janssen at United European Gastroenterology Week (UEGW) Demonstrates Long-Term Safety Profile for STELARA® (ustekinumab) in Older Patients Across Approved Indications
Published: 2021-10-04 (Crawled : 13:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.98%
H: 0.63%
C: -0.48%
europe order
Adamis Announces Appointment of Meera Desai, Ph.D., to Board of Directors
Published: 2021-10-04 (Crawled : 12:00) - globenewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.98%
H: 0.63%
C: -0.48%
NKTR | News | $1.39 -2.11% -2.16% 960K
|
Health Technology
|
| O: 2.74%
H: 1.58%
C: -1.58%
ADMP | $0.7751 0.86% 2.6% 120K
|
Health Technology
|
| O: 3.98%
H: 3.96%
C: 2.97%
Xencor Enters Global Collaboration and License Agreement With Janssen to Advance Plamotamab and XmAb CD28 Bispecific Antibody Combinations for the Treatment of Patients With B-Cell Malignancies
Published: 2021-10-04 (Crawled : 12:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.98%
H: 0.63%
C: -0.48%
XNCR | $19.05 3.7% 3.57% 760K
|
Health Technology
|
| O: 2.87%
H: 5.64%
C: 5.37%
treatment collaboration antibody license t-cell
Active Pharmaceutical Ingredient (API) Market to Cross $357,005.7 Million Value by 2030, says P&S Intelligence
Published: 2021-10-04 (Crawled : 10:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: 1.49%
H: 0.0%
C: -0.77%
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: 6.28%
H: 0.0%
C: -0.2%
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: 0.96%
H: 0.0%
C: 0.0%
TEVA | $13.01 -0.68% 7.5M
|
Health Technology
|
| O: -1.95%
H: 2.51%
C: 0.73%
TAK | News | $13.23 -1.12% 0.0% 920K
|
Health Technology
|
| O: -0.28%
H: 0.49%
C: -1.16%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.83%
H: 1.0%
C: 0.15%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.98%
H: 0.63%
C: -0.48%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 0.1%
H: 1.02%
C: 0.37%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -1.53%
H: 1.05%
C: -1.29%
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: 0.13%
H: 1.05%
C: -0.79%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.71%
H: 1.25%
C: -0.1%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.54%
H: 0.77%
C: 0.17%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: 1.28%
H: 0.83%
C: 0.82%
Addex to Present at the 10th International Meeting on Metabotropic Glutamate Receptors
Published: 2021-10-04 (Crawled : 06:00) - globenewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.98%
H: 0.63%
C: -0.48%
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.